Cargando…
Reevaluation of adverse drug reactions of psychiatric drugs under the chinese drug volume-based procurement policy
BACKGROUND: The "4 + 7" volume-based procurement is a "large group purchase" led by the Chinese government, with the aim of reducing the price of medicines by trading volume for price. Although the "4 + 7" drugs had passed the national consistency evaluation, the advers...
Autores principales: | Du, Zhiqiang, Jiang, Ying, Shen, Yuan, Zhou, Qin, Wang, Shushan, Zhu, Haohao, Ji, Yingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969372/ https://www.ncbi.nlm.nih.gov/pubmed/35361211 http://dx.doi.org/10.1186/s12913-022-07851-4 |
Ejemplares similares
-
The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis
por: Yang, Ying, et al.
Publicado: (2021) -
Drug procurement, the Global Fund and misguided competition policies
por: Tren, Richard, et al.
Publicado: (2009) -
Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
por: Wang, Ni, et al.
Publicado: (2021) -
The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China
por: Chen, Lei, et al.
Publicado: (2020) -
The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis
por: Wang, Xiao, et al.
Publicado: (2023)